Document:

EXHIBIT
10.16

 

DEMAND
CONVERTIBLE PROMISSORY NOTE AMENDMENT FOR

RENEWAL
OF NOTES, DATED APRIL 28, 2015, JUNE 8, 2015 AND JUNE 13, 2016

 

This
DEMAND CONVERTIBLE PROMISSORY NOTE AMENDMENT (the “Amendment”) is made and entered into on this 19th day of
June, 2017 (the “Effective Date”), by and between Roy Meadows, an individual, with an address of 207
Jasmine Drive, Longwood, Florida 32779, (the “Holder”), and Lifestyle Medical Network, Inc., a Nevada
corporation, (the “Company”), with an address of 121 South Orange Ave., Suite 1500, Orlando Florida 32801, and
amends the terms and conditions of those three (3) DEMAND CONVERTIBLE PROMISSORY NOTES, dated April 28, 2015, June 8, 2015
and June 13, 2016 respectively (collectively, the “Notes” and individually, a “Note”), by and between
the Parties (as hereinafter defined) and henceforth is a part thereof. (Holder and the Company may be referred to
collectively as the “Parties”, or individually as a “Party”.)

 

A.
Terms and Conditions for Renewal of the Notes

 

As
of the Effective Date, the Company and Holder hereby agree to the following changes in terms and conditions of the Notes and the
following requirements to be met by the Company as conditions for the Renewal of each Note per each Note’s Section 3. As
a result of the Parties mutual agreement to the following, and the Companies compliance with the following, the Parties hereby
agree to amend each Note whereby each Note shall be renewed for an additional 365 days from its respective Maturity Date, such
that:

 

(a)
the Note dated April 28, 2015 with a Maturity Date of April 28, 2017 (“April 2015 Note Renewal Date”), following its
renewal on its first year anniversary on April 28, 2016, is hereby renewed to April 28, 2018;

 

(b)
the Note dated June 8, 2015 with a Maturity Date of April 28, 2017(“June 2015 Note Renewal Date”), following its renewal
on its first year anniversary on June 8, 2016, is hereby renewed to June 8, 2018;

 

(c)
and the Note dated June 13, 2016 with a Maturity Date of June 13, 2017 (“June 2016 Note Renewal Date”), is hereby
renewed to June 13, 2018 (The “Renewals”).

 

1.
Renewal Fees and Outstanding Balances of the Notes. The Parties have agreed that as a condition of the Holder allowing
the Renewals, that the Company shall pay a renewal fee per Note, per each Note’s Section 3, which is 10% of the outstanding
balance of each Note as of its Maturity Date (each a “Renewal Fee”):

 

(a)
The outstanding balance of the Note dated April 28, 2015 on its April 2017 Renewal Date, before the addition of the 2017 renewal
fee, was $344,960.00 (including accrued and unpaid interest of $36,960.00). Therefore, its Renewal Fee is $34,496.00, resulting
in an outstanding balance on April 28, 2017 of $379,456.00 per Exhibit A.

 

(b)
The outstanding balance of the Note dated June 8, 2015 on its June 2017 Renewal Date, before the addition of the 2017 renewal
fee, was $344,422.33 (including accrued and unpaid interest of $36,902.39). Therefore, its Renewal Fee is $34,442.23, resulting
in an outstanding balance on June 8, 2017 of $378,864.56 per Exhibit B.

 

(c)
The outstanding balance of the Note dated June 13, 2016 on its June 2017 Renewal Date, before the addition of the 2017 renewal
fee, was $279,781.57 (including accrued and unpaid interest of $29,682.94). Therefore, its Renewal Fee is $27,978.16, resulting
in an outstanding balance on June 13, 2017 of $307,759.73 per Exhibit C.

 

(d)
In connection with the Renewals, the Holder has agreed to allow, and the Company has accepted, that each Note’s respective
Renewal Fee shall be added to the outstanding balance of each Note as of its Maturity Date, and that said Renewal Fee per Note
shall contiguously accrue interest under the terms and conditions of the Note until the Note is paid in full, including principal,
interest, fees, and the fulfillment of any and all additional terms and conditions required under each Note.

 

(e)
Each Note until paid in full, including principal, interest, fees, and the fulfillment of any and all additional terms and
conditions under each Note respectively, shall contiguously accrue interest and fees on an ongoing basis per its terms and conditions.

 

    	 		 

     

    

 

2.
Reaffirmation of Conversion Price. Specific to each of the Notes, the second last sentence of Section “5. Conversion
of Promissory Note.”, item “(a) Conversion Rights; Conversion Dates; Conversion Price.”, remains amended as
follows: “Any amount so converted will be converted into common stock at a conversion price of $.10 per share (the ‘Conversion
Price’).”

 

3.
Reaffirmation of Exercise Price. Specific to each of the Notes, the third sentence of Section 3 “Renewal.”,
item “(c)” of each Note, remains amended as follows: “The Exercise Price of each such issuance of Warrants shall
be the same as per Section 8, “Equity Bonus of Common Stock Purchase Warrant”, wherein said Exercise Price is hereby
changed to $0.025 per share.

 

4.
Renewal Warrant Shares. In addition to the Renewal Fee of each Note, per Section 3 “Renewal.” of each Note,
a Common Stock Purchase Warrant (the “Renewal Warrant”, or “Warrant”), in form and content including a
“cashless” exercise feature, identical to Exhibit D, shall be issued to the Holder by the Company at any Exercise
Price of $0.025 per share (per “3.” above) in aggregate total of the sum of the following:

 

(a)
For the Renewal of the Note dated April 28, 2015, the quantity of shares issuable under the Renewal Warrant shall be equal to
the Renewal Fee of $34,496.00 per Exhibit A, divided by the Conversion Price (per Section 3 “Renewal.”, item “(c)”,
as amended per item “2.” above) of $.10 per share, rounded up to the next highest share, or 344,960 shares.

 

(b)
For the Renewal of the Note dated June 8, 2015, the quantity of shares issuable under the Renewal Warrant shall be equal to the
Renewal Fee of $34,442, per Exhibit B, divided by the Conversion Price (per Section 3 “Renewal.”, item “(c)”,
as amended per item “2.” above) of $.10 per share, rounded up to the next highest share, or 344,422 shares.

 

(c)
For the Renewal of the Note dated June 13, 2016, the quantity of shares issuable under the Renewal Warrant shall be equal to the
Renewal Fee of $27,978, per Exhibit C, divided by the Conversion Price (per Section 3 “Renewal.”, item “(c)”,
as amended per item “2.” above) of $.10 per share, rounded up to the next highest share, or 279,782 shares.

 

Therefore,
the total quantity of shares to be issuable under the single Renewal Warrant for all three (3) Notes is 969,164 shares of common
stock (the “Renewal Warrant Shares”). The Company had agreed to issue the Renewal Warrant Shares on the date of May
16, 2017.

 

5.
Board of Directors Resolution Authorizing Issuance of Warrant. In addition to the issuance per “4.” above of
the 969,164 Renewal Warrant Shares, the Company shall provide to the Holder simultaneously with said delivery, a copy of its Board
of Directors resolution authorizing the Warrant issuance.

 

The
Parties agree and acknowledge that any default or breach of any of the preceding terms and conditions of this Amendment, which
default or breach is not cured to the satisfaction of the Holder, in his sole judgment and discretion, within five (5) business
days of said default or breach, for which a notice of such default or breach by the Holder to the Company shall not be required
in writing to effect such default or breach which may be declared by the Holder upon the date of its occurrence, shall render
this Amendment null and void immediately as if it were never made. As a result of this Amendment becoming null and void per the
preceding, any outstanding balances of the Notes, including principal, interest, fees, and other charges per the terms and conditions
of the Notes, shall be declared immediately due and payable. 

 

B.
General Provisions

 

1.
All other terms and conditions specific to each Note, including Section 17. “Governing Law.”, shall remain in full
force and effect and remain unchanged.

 

2.
This Amendment may not be changed or modified except by written agreement signed by both of the Parties.

 

3.
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which shall constitute
one and the same instrument.

 

    	 	2	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the Effective Date.

 

	HOLDER:
    	 	THE
    COMPANY:
	 	 	 
	Roy
    Meadows 	 	Lifestyle
    Medical Network, Inc.
	an
    individual a Nevada corporation	 	 
	 	 	 	 	 
	By:
    	/s/
    Roy Meadows	 	By:
    	/s/
    Chris Smith
	 	Roy
    Meadows	 	 	Christopher
    Smith, CEO

 

    	 	3	 

     

    

 

EXHIBIT
A

 

Date
4/29/2015 4/28/2016 4/28/2016 4/28/2016

 

Amount
Advanced 250,000.00

Amount
Converted

Renewal
Fee 28,000.00 3 4,496.00

Balance
Outstanding on Date 250,000.00 308,000.00 308,000.00 3 79,456.00

Calculation
Date 4/28/2016 4/28/2016 4/28/2017 4/28/2017

Days
Outstanding 365 0 365 365

Interest
Rate 12.00% 12.00% 12.00% 12.00%

Interest
Due as of Calculation Date 30,000.00 - 36,960.00 -

Total
Outstanding 280,000.00 308,000.00 344,960.00 3 79,456.00

Lifestyle
Medical Networks, Inc. (LMNK)

Roy
Meadows Demand Conv Prom Note, 4/28/15

 

EXHIBIT
B

 

Date
6/12/2015 6/19/2015 6/8/2016 6/8/2016 6/8/2017

 

Amount
Advanced 150,000.00 100,000.00

Amount
Converted

Renewal
Fee 27,956.36 34,442.23

Balance
Outstanding on Date 150,000.00 250,345.21 307,519.94 307,519.94 378,864.56

Calculation
Date 6/19/2015 6/8/2016 6/8/2016 6/8/2017 6/8/2017

Days
Outstanding 7 355 0 365 0

Interest
Rate 12.00% 12.00% 12.00% 12.00% 12.00%

Interest
Due as of Calculation

Date
345.21 29,218.37 - 36,902.39 -

Total
Outstanding 150,345.21 279,563.58 307,519.94 344,422.33 378,864.56

Lifestyle
Medical Networks, Inc. (LMNK)

Roy
Meadows Demand Conv Prom Note, 6/8/2015

 

EXHIBIT
C

 

Date
6/14/2016 6/17/2016 6/13/2017

 

Amount
Advanced 100,000.00 150,000.00

Amount
Converted

Renewal
Fee 27,978.16

Balance
Outstanding on Date 100,000.00 250,098.63 307,759.73

Calculation
Date 6/17/2016 6/13/2017 6/13/2017

Days
Outstanding 3 361 0

Interest
Rate 12.00% 12.00% 12.00%

Interest
Due as of Calculation Date 98.63 29,682.94 -

Total
Outstanding 100,098.63 279,781.57 307,759.73

Lifestyle
Medical Networks, Inc. (LMNK)

Roy
Meadows Demand Conv Prom Note, 6/13/16

 

    	 	4	 

     

    

 

EXHIBIT
D

 

Warrant
No. ______

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (“THE ACT”),
OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF
EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE LAWS, (ii) TO THE EXTENT APPLICABLE,
RULE 144 UNDER THE ACT (OR ANY SIMILAR RULE UNDER THE ACT RELATING TO THE DISPOSITION OF SECURITIES), OR (iii) AN OPINION OF COUNSEL,
IF SUCH OPINION SHALL BE REASONABLY SATISFACTORY TO COUNSEL TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND
APPLICABLE STATE LAW IS AVAILABLE.

 

COMMON
STOCK PURCHASE WARRANT

LIFESTYLE
MEDICAL NETWORK, INC.

(Incorporated
under the laws of the State of Nevada)

 

This
“Common Stock Purchase Warrant”, (“Warrant”), effective May 16, 2017, entitles Roy Meadows,
an individual, residing at 207 Jasmine Lane, Longwood, Florida 32779, or his successors or assigns, (the “Holder”),
for value received, subject to the terms and conditions set forth herein, to purchase from Lifestyle Medical Network, Inc.,
a Nevada corporation (the “Company”), its successors or assigns, in whole or in part, nine hundred and sixty-nine
thousand, one hundred and sixty-four (969,164) shares of common stock of the Company (the “Common Stock”), which
shall be fully paid and nonassessable securities of the Company (the “Warrant Securities”), upon payment of an exercise
price per share of Common Stock by the Holder, or his successors or assigns, of $0.025 per share, and in accordance to the other
terms and conditions herein.

 

1.
Exercisability. In accordance with federal and state securities laws and regulation, this Warrant may be exercised in
whole or in part, beginning on the date which is the earlier of (a) six (6) months from the Company being in compliance with the
requirements of being a Reporting Company (as defined as an issuer with a class of securities registered under Section 12 or subject
to Section 15(d) of the Securities Exchange Act of 1934, as amended, the “Exchange Act”, which is subject to the periodic
and current reporting requirements of Section 13 or 15(d) of the Securities Exchange Act and is thereinafter referred to as a
SEC “Reporting Company”), or (b) one (1) year from the date hereof if the Company is no longer, or a delinquent Reporting
Company, and up to the date which is five (5) years from the date hereof (the “Exercise Period”), or through May
16, 2022, by presentation and surrender hereof to the Company of a notice of election to purchase duly executed and accompanied
by payment by check or wire transfer of the Exercise Price for such shares to the Company at the Company’s offices, or exercised
in accordance with Section 6 (“Cashless Exercise”) below. Notwithstanding the above, the Holder may not exercise this
Warrant if, at the time of such exercise, the amount of common stock issued upon exercise, when added to other shares of Company
common stock owned by the Holder or which can be acquired by Holder upon exercise or conversion of any other instrument, would
cause the Holder to own more than four and ninety-nine-tenths percent (4.99%) of the Company’s outstanding common stock
(the “Ownership Limitation”) if the Company is a Reporting Company. Such Ownership Limitation shall be increased to
nine and ninety-nine-tenths percent (9.99%) of the Company’s outstanding common stock should the Company file with the SEC
to cease to be a Reporting Company.

 

    	 	5	 

     

    

 

2.
Manner of Exercise. In case of the purchase of less than all the Warrant Securities, at the request of the Holder the
Company shall cancel this Warrant upon the surrender hereof and shall execute and deliver a new warrant of like tenor for the
balance of the Warrant Securities. Upon the exercise of this Warrant, the issuance of certificates for securities, properties
or rights underlying this Warrant shall be made forthwith without charge to the Holder including, without limitation, any tax
that may be payable in respect of the issuance thereof; provided, however, that the Company shall not be required to pay any tax
in respect of income or capital gain of the Holder.

 

The
Company shall cause the Warrant Securities to be delivered to the Holder within five (5) business days of any Exercise by the
Holder (the “Issuance”), together with a Board of Directors resolution of the Company, and an attorney’s opinion
letter, provided at the sole expense of the Company, addressed to the Company’s transfer agent, verifying the validity of
the Issuance to the Holder.

 

If
and to the extent this Warrant is exercised, in whole or in part, the Holder shall be entitled to receive a certificate or certificates
representing the Warrant Securities so purchased, upon presentation and surrender to the Company of the form of election to purchase
attached hereto duly executed, and accompanied by payment of the purchase price.

 

3.
Adjustment in Number of Shares.

(a)
Adjustment for Reclassifications. In case at any time or from time to time after the issue date the holders of the Common Stock
of the Company (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have
received, or, on or after the record date fixed for the determination of eligible stockholders, shall have become entitled to
receive, without payment therefore, other or additional stock or other securities or property (including cash) by way of stock
split, spin-off, reclassification, combination of shares or similar corporate rearrangement (exclusive of any stock dividend of
its or any subsidiary’s capital stock), then and in each such case the Holder of this Warrant, upon the exercise hereof
as provided in Section 1, shall be entitled to receive the amount of stock and other securities and property which such Holder
would hold on the date of such exercise if on the issue date he had been the holder of record of the number of shares of Common
Stock of the Company called for on the face of this Warrant and had thereafter, during the period from the issue date, to and
including the date of such exercise, retained such shares and/or all other or additional stock and other securities and property
receivable by him as aforesaid during such period, giving effect to all adjustments called for during such period. In the event
of any such adjustment, the Exercise Price shall be adjusted proportionally.

(b)
Adjustment for Reorganization, Consolidat ion, Merger In case of any reorganization of the Company (or any other corporation the
stock or other securities of which are at the time receivable on the exercise of this Warrant) after the issue date, or in case,
after such date, the Company (or any such other corporation) shall consolidate with or merge into another corporation or convey
all or substantially all of its assets to another corporation, then and in each such case the Holder of this Warrant, upon the
exercise hereof as provided in Section 1 at any time after the consummation of such reorganization, consolidation, merger or conveyance,
shall be entitled to receive, in lieu of the stock or other securities or property to which such Holder would be entitled had
the Holder exercised this Warrant immediately prior thereto, all subject to further adjustment as provided herein; in each such
case, the terms of this Warrant shall be applicable to the shares of stock or other securities or property of any successor of
the Company as the result of any reorganization, consolidation or merger, receivable upon the exercise of this Warrant after consummation
of any reorganization, consolidation of merger.

 

    	 	6	 

     

    

 

4.
No Requirement to Exercise. Nothing contained in this Warrant shall be construed as requiring the Holder to exercise this
Warrant prior to or in connection with the effectiveness of a registration statement.

 

5.
No Stockholder Rights. Unless and until this Warrant is exercised, this Warrant shall not entitle the Holder hereof to
any voting rights or other rights as a stockholder of the Company, or to any other rights whatsoever except the rights herein
expressed, and, no dividends shall be payable or accrue in respect of this Warrant.

 

6.
Cashless Exercise. In lieu of delivering the Exercise Price in Cash, Holder, at his option, may instruct the Company to
retain, in payment of the Exercise Price, a number of the shares of Common Stock (the “Payment Shares”) equal to the
quotient of the aggregate Exercise Price of the Warrants then being exercised divided by the Market Price of such Payment Shares
as of the date of exercise, and to deduct the number of Payment Shares from the shares of Common Stock to be delivered to such
holder. For purposes of this Warrant, Market Price shall mean the closing bid price of the Company’s common stock on the
trading day immediately before the exercise date. Notwithstanding the above, this Section 6 shall only be applicable provided
that the Company is trading on a recognized exchange on the date of exercise. For purposes of Rule 144 and sub-section (d)(3)(ii)
thereof, it is intended, understood and acknowledged that the Common Stock issued upon Exercise of this Warrant in a Cashless
Exercise transaction shall be deemed to have been acquired at the time this Warrant was issued. Moreover, it is intended, understood
and acknowledged that the holding period for the Common Stock issued upon Exercise of this Warrant in a Cashless Exercise transaction
shall be deemed to have commenced on the date this Warrant was issued.

 

7.
Exchange. This Warrant is exchangeable upon the surrender hereof by the Holder to the Company for a new warrant of like
tenor representing in the aggregate the right to purchase the number of Warrant Securities purchasable hereunder, each of such
new warrants to represent the right to purchase such number of Warrant Securities as shall be designated by the Holder at the
time of such surrender. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
or mutilation of this Warrant, and, in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to
it and reimbursement to the company of all reasonable expenses incidental thereto, and upon surrender and cancellation hereof,
if mutilated, the Company will make and deliver a new warrant of like tenor and amount, in lieu hereof.

 

8.
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of
securities upon the exercise of this Warrant, nor shall it be required to issue scrip or pay cash in lieu of fractional interests.
All fractional interests shall be eliminated by rounding any fraction up to the nearest whole number of securities, properties
or rights receivable upon exercise of this Warrant.

 

9.
Reservation of Securities. The Company shall at all times reserve and keep available out of its authorized shares of Common
Stock or other securities, solely for the purpose of issuance upon the exercise of this Warrant, such number of shares of Common
Stock or other securities, properties or rights as shall be issuable upon the exercise hereof. The Company covenants and agrees
that, upon exercise of this Warrant and payment of the Principal Value, all shares of Common Stock and other securities issuable
upon such exercise shall be duly and validly issued, fully paid, non-assessable and not subject to the preemptive rights of any
stockholder.

 

    	 	7	 

     

    

 

10.
Notices to Holder. If at any time prior to the expiration of this Warrant or its exercise, any of the following events
shall occur:

 

(a)
The Company shall take a record of the holders of any class of its securities for the purpose of entitling them to receive a dividend
or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of current or retained
earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company; or

 

(b)
The Company shall offer to all the holders of a class of its securities any additional shares of capital stock of the Company
or securities convertible into or exchangeable for shares of capital stock of the Company, or any option or warrant to subscribe
therefor; or

 

(c) A dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or merger)
or a sale of all or substantially all of its property, assets and business as an entirety shall be proposed, then, in any one
or more said events, the Company shall give written notice of such event to the Holder at least fifteen (15) days prior to the
date fixed as a record date or the date of closing the transfer books for the determination of the stockholder entitled to such
dividend, distribution, convertible or exchangeable securities or subscription rights, or entitled to vote on such proposed dissolution,
liquidation, winding up or sale. Such notice shall specify such record date or the date of closing the transfer books, as the
case may be.

 

11.
Transferability. This Warrant may be transferred or assigned by the Holder without notice or approval by the Company.

 

12
.. Informational Requirements. The Company will transmit to t h e Holder such information, documents and reports as are
generally distributed to stockholders of the Company concurrently with the distribution thereof to such stockholders.

 

13.
Notice. Notices to be given to the Company or the Holder shall be deemed to have been sufficiently given if delivered
personally or sent by overnight courier or messenger, or by facsimile transmission, to the last known address for each party.

 

14.
Consent to Jurisdiction and Service. The Company consents to the jurisdiction of any court of the State of Florida or
Nevada, and of any federal court located in Florida or Nevada, in any action or proceeding arising out of or in connection with
this Warrant, wherein said court shall apply Nevada law. The Company waives personal service of any summons, complaint or other
process in connection with any such action or proceeding and agrees that service thereof may be made, by certified mail directed
to the Company at the location provided in Section 13 hereof, or, in the alternative, in any other form or manner permitted by
law.

 

15.
Successors. All the covenants and provisions of this Warrant shall be binding upon and inure to the benefit of the Company,
the Holder and their respective legal representatives, successors and assigns.

 

16.
Attorneys Fees. In the event the holder hereof shall refer this Warrant to an attorney to enforce the terms hereof, the
Company agrees to pay all the costs and expenses incurred in attempting or effecting collection hereunder, including reasonable
attorney's fees, whether or not suit is instituted.

 

17.
Governing Law. THIS WARRANT SHALL BE GOVERNED, CONSTRUED AND INTERPRETED UNDER THE LAWS OF THE STATE OF NEVADA, WITHOUT
GIVING EFFECT TO THE RULES GOVERNING CONFLICTS OF LAW.

 

18.
Consent to Jurisdiction and Service of Process. The Company consents to the jurisdiction of the courts of the State of
Florida and of any state and federal court located in the County of Seminole, Florida.

 

    	 	8	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by the signature of its Officer whose name appears below
and to be delivered in Orlando, Florida on this 16th day of May, 2017.

 

	LIFESTYLE
    MEDICAL NETWORK, INC.	 
	A Nevada corporation	 
	 	 	 
	By:
    	 	 
	 	Christopher
    Smith, CEO	 
	 	 	 
	Acknowledged:	 
	 	 	 
	By:	 	 
	 	Roy
    Meadows	 

 

    	 	9	 

     

    

 

NOTICE
OF EXERCISE

 

TO:
LIFESTYLE MEDICAL NETWORK, INC.

 

(1)
The undersigned hereby elects to purchase ____________ shares of the Common stock of Lifestyle Medical Network, Inc., a Nevada
corporation, (the “Company”), pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise
price in full, together with all applicable transfer taxes, if any; or

 

The
undersigned hereby elects to purchase ________ shares of the common stock of the Company pursuant to the terms of the cashless
exercise provisions set forth in Section 6 of the attached Warrant, and shall tender payment of all applicable transfer taxes,
if any.

 

(2)
Please issue a certificate or certificates representing said shares of the Company’s common stock in the name of the undersigned
or in such other name as is specified below:

 

(Name)
____________________________________________________

(Address)___________________________________________________

(Date)
(Signature)

(Print
name) _________________________________________________

 

 

10EXHIBIT 10.17

 

Employment
agreement

 

Lifestyle Medical Network Inc.

 

THIS EMPLOYMENT AGREEMENT
(“Agreement”) is made as of July 1,
2017 (“Effective Date”), by and between CHRISTOPHER P. SMITH of Lake Mary, Florida (“Executive”)
and LIFESTYLE MEDICAL NETWORK Inc., a Nevada Corporation (the “Company”). 

 

PREAMBLE

 

WHEREAS, the Board of Directors
of the Company recognizes Executive's previous and potential contribution to the growth and success of the Company and desires
to assure the Company of Executive's employment in an executive capacity as Chief Executive Officer and to compensate him therefore;

 

WHEREAS, Executive wants to be
employed by the Company and to commit himself to serve the Company on the terms herein provided;

 

NOW, THEREFORE, in consideration
of the foregoing and of the respective covenants and agreements of the parties, the parties agree as follows:

 

1       General Definitions.

 

“Exchange Act” shall refer to the Securities
Exchange Act of 1934, as amended.

 

“Benefits”
shall mean all the fringe benefits approved by the Board from time to time and established by the Company for the benefit of Executives
generally and/or for key Executives of the Company as a class, including, but not limited to, regular holidays, vacations, absences
resulting from illness or accident, health insurance, disability and medical plans (including dental and prescription drug), group
life insurance, and pension, profit-sharing and stock bonus plans or their equivalent.

 

“Board” shall mean the Board of Directors
of the Company, together with an executive committee thereof (if any), as same shall be constituted from time to time.

 

“Business” shall refer to the business of
the Company which is described as: Medical Services Management.

 

“Chairman” shall mean the individual
designated by the Board from time to time as its Chairman.

 

    	 	Page 1 of 17	Initials:       /_    

     

    

 

“Change of Control” shall mean the occurrence
of one or more of the following three events:

 

(i) After the Effective Date
of this Agreement, any person becomes a beneficial owner (as such term is defined in Rule 13d- 3 promulgated under the Exchange
Act), directly or indirectly, of securities representing fifty percent (50%) or more of the total number of votes that may be cast
for the election of directors of the Company;

 

(ii) Within two (2) years after
a merger, consolidation, liquidation or sale of assets involving the Company, or a contested election of a Company director, or
any combination of the foregoing, the individuals who were directors of the Company immediately prior thereto shall cease to constitute
a majority of the Board; or

 

(iii) Within two years after
a tender offer or exchange offer for voting securities of the Company, the individuals who were directors of the Company immediately
prior thereto shall cease to constitute a majority of the Board.

 

Notwithstanding anything to
the contrary in this Agreement, Executive acknowledges that the Company is seeking to raise capital from investors which would
result in such investors acquiring a significant interest in the Company. Provided that Executive consents in writing to or votes
as a director in favor of the infusion of capital to the Company in exchange for a significant equity interest in the Company,
no Change in Control shall be deemed to have occurred.

 

“Chief Executive Officer”
shall mean the individual having responsibility to the Board for direction and management of the executive and operational affairs
of the Company and who reports and is accountable only to the Board.

 

“Code” shall refer to the Internal Revenue
Code of 1986, as amended.

 

“Company”
shall mean Lifestyle Medical Network Inc., a Nevada corporation, together with such subsidiaries and affiliates of the Company,
as may from time to time exist.

 

“Competitor” shall mean any person, entity,
company, or corporation engaged in the same Business in the same Territory as the Company.

 

“Disability”
shall mean a written determination by a physician mutually agreeable to the Company and Executive (or, in the event of Executive's
total physical or mental disability, Executive's legal representative) that Executive is physically or mentally unable to perform
his duties of Chief Executive Officer under this Agreement and that such disability can reasonably be expected to continue for
a period of six (6) consecutive months or for shorter periods aggregating one hundred and eighty (180) days in any twelve (12)-month
period.

 

“Executive”
shall mean Christopher P. Smith and, if the context requires, his heirs, personal representatives, and permitted successors and
assigns.

 

“Person” shall
mean any natural person, incorporated entity, limited or general partnership, business trust, association, agency (governmental
or private), division, political sovereign, or subdivision or instrumentality, including those groups identified as “persons”
in §§13(d)(3) and 14(d)(2) of the Exchange Act.

 

    	 	Page 2 of 17	Initials:       /_    

     

    

 

“Reorganization”
shall mean any transaction, or any series of transactions consummated in a 12-month period, pursuant to which any Person acquires
(by merger, acquisition, or otherwise) all or substantially all of the assets of the Company or the then outstanding equity securities
of the Company and the Company is not the surviving entity, the Company being deemed surviving if and only if the majority of the
Board of Directors of the ultimate parent of the surviving entity were directors of the Company prior to its organization.

 

“Term” shall
mean a period Three (3) years commencing with the Effective Date hereof (the ”Initial Term”). On the third (3rd)
anniversary of the Effective Date, and on each subsequent annual anniversary of the effective date thereafter, this Agreement shall
be automatically extended for an additional year (the “Renewal Term(s)”) unless either party notifies the other in
writing more than ninety (90) days prior to the relevant anniversary date that this Agreement is no longer to be extended. The
Initial Term and each subsequent Renewal Term shall constitute the “Term” of this Agreement and all references to the
“Term” shall apply accordingly.

 

“Territory”
shall mean within a fifty (50) mile radius of any area in the United States and any equivalent section or area of any country in
which the Company has an office, revenue- producing customers, or activities.

 

2       Positions, Responsibilities,
and Terms of Employment.

 

2.01 Position. Executive
shall serve as Chief Executive Officer and in such additional management position(s) as the Board shall designate. In this capacity
Executive shall, subject to the bylaws of the Company, and to the direction of the Board, serve the Company by performing such
duties and carrying out such responsibilities as are normally related to the position of Chief Executive Officer in accordance
with the standards of the industry. The Board shall either vote or recommend to the shareholders of the Company, as appropriate,
that during the term of employment pursuant to this Agreement: (i) Executive be nominated for election as a director at each meeting
of shareholders held for the election of directors; (ii) Executive be elected to and continued in the office of Chief Executive
Officer of the Company and such of its subsidiaries as he may select; (iii) Executive be elected to and continued on the Board
of each subsidiary of the Company; (iv) if the Board of the Company or any of its subsidiaries shall appoint an executive committee
(or similar committee authorized to exercise the general powers of the Board), Executive be elected to and continued on such committee;
and (v) neither the Company nor any of its subsidiaries shall confer on any other officer or Executive authority, responsibility,
powers or prerogatives superior or equal to the authority, responsibility, prerogatives and powers vested in Executive hereunder.

 

2.02 Best Efforts Covenant.
Executive will, to the best of his ability, devote a substantial portion of his professional and business time and best efforts
to the performance of his duties for the Company and its subsidiaries and affiliates. However, this will not prevent Executive
from engaging in other business activities with other business entities that do not interfere with his responsibilities as Chief
Executive Officer.

 

2.03 Non-Exclusivity; No Adverse
Participation. During this Agreement’s Term, Executive will be free to engage in any other employment, occupation or
business enterprise so long as they do not interfere with his ability to perform his duties under this Agreement. However, Executive
agrees not to acquire, assume, or participate in, directly or indirectly, any position, investment, or interest in the Territory
adverse or antagonistic to the Company, its business or prospects, financial or otherwise, or take any action towards any of the
foregoing, except that such acquisition, assumption or participation shall be permitted if such position, investment or interest
is approved by the Board of Directors of the Company. The provisions of this Section shall not prevent Executive from owning shares
of any Competitor of the Company so long as such shares (i) do not constitute more than 5% of the outstanding equity of such Competitor,
and (ii) are regularly traded on a recognized exchange or listed for trading by NASDAQ in the over-the-counter market.

 

2.04 Post-Employment Non-competition/Non-Solicitation
Covenant. Except with the prior written consent of the Board, Executive shall not engage in activities in the Territory either
on Executive's own behalf or that of any other business organization, which are in direct or indirect competition with the Company
for a period of one (1) year subsequent to Executive's voluntary withdrawal from employment with the Company (except for a termination
pursuant to a Change in Control), or the Company’s termination of Executive's employment for Cause. Executive and the Company
expressly declare that the territorial and time limitations contained in this Section and the definition of “Territory”
are entirely reasonable at this time and are properly and necessarily required for the adequate protection of the business and
intellectual property of the Company. If such territorial or time limitations, or any portions thereof, are deemed to be unreasonable
by a court of competent jurisdiction, whether due to passage of time, change of circumstances or otherwise, Executive and the Company
agree to a reduction of said territorial and/or time limitations to such areas and/or periods of time as said court shall deem
reasonable.

 

    	 	Page 3 of 17	Initials:       /_    

     

    

 

For a period of one (1) year
subsequent to Executive's voluntary withdrawal from employment with the Company (except for a termination pursuant to a Change
in Control), or the Company’s termination of Executive's employment for Cause, Executive will not without the express prior
written approval of the Board (i) directly or indirectly, in one or a series of transactions, recruit, solicit or otherwise induce
or influence any proprietor, partner, stockholder, lender, director, officer, executive, sales agent, joint venturer, investor,
lessor, supplier, customer, agent, representative or any other person which has a business relationship with the Company or had
a business relationship with the Company within the twenty-four (24) month period preceding the date of the incident in question,
to discontinue, reduce, or modify such employment, agency or business relationship with the Company, or (ii) employ or seek to
employ or cause any business organization in direct or indirect competition with the Company to employ or seek to employ any person
or agent who is then (or was at any time within six months prior to the date Executive or the competitive business employs or seeks
to employ such person) employed or retained by the Company. Notwithstanding the foregoing, nothing herein shall prevent Executive
from providing a letter of recommendation to an executive with respect to a future employment opportunity.

 

2.05 Confidential Information.
Executive recognizes and acknowledges that the Company’s trade secrets and proprietary information and know-how, as they
may exist from time to time (“Confidential Information”), are valuable, special and unique assets of the Company’s
business, access to and knowledge of which are essential to the performance of Executive's duties hereunder. Executive will not,
during or after the term of his employment by the Company, in whole or in part, disclose such secrets, information or know-how
to any Person for any reason or purpose whatsoever, nor shall Executive make use of any such property for his own purposes or for
the benefit of any Person (except the Company) under any circumstances during or after the term of his employment, provided that
after the term of his employment these restrictions shall not apply to such secrets, information and know-how which are then in
the public domain (provided that Executive was not responsible, directly or indirectly, for such secrets, information or processes
entering the public domain without the Company’s consent). Executive shall have no obligation hereunder to keep confidential
any Confidential Information if and to the extent disclosure of any thereof is specifically required by law; provided, however,
that in the event disclosure is required by applicable law, Executive shall provide the Company with prompt notice of such requirement,
prior to making any disclosure, so that the Company may seek an appropriate protective order. Executive agrees to hold as the Company’s
property all memoranda, books, papers, letters, customer lists, processes, computer software, records, financial information, policy
and procedure manuals, training and recruiting procedures and other data, and all copies thereof and therefrom, in any way relating
to the Company’s business and affairs, whether made by him or otherwise coming into his possession, and on termination of
his employment, or on demand of the Company at any time, to deliver the same to the Company. Executive agrees that he will not
use or disclose to other executives of the Company, during the term of this Agreement, confidential information belonging to his
former employers.

 

Executive shall use his best
efforts to prevent the removal of any Confidential Information from the premises of the Company, except as required in his normal
course of employment by the Company. Executive shall use his best efforts to cause all persons or entities to whom any Confidential
Information shall be disclosed by him hereunder to observe the terms and conditions set forth herein as though each such person
or entity was bound hereby.

 

2.06 Records, Files. All
records, files, drawings, documents, equipment and the like relating to the business of the Company which are prepared or used
by Executive during the Term of his employment under this Agreement shall be and shall remain the sole property of the Company.

 

2.07 Hired to Invent.
Executive agrees that every improvement, invention, process, apparatus, method, design and any other creation that Executive may
invent, discover, conceive, or originate by himself or in conjunction with any other Person during the term of Executive's employment
under this Agreement that relates to the business carried on by the Company during the Term of Executive's employment under this
Agreement shall be the exclusive property of the Company. Executive agrees to disclose to the Company every patent application,
notice of copyright, or other action taken by Executive or any affiliate or assignee to protect intellectual property during the
twelve (12) months following Executive's termination of employment at the Company, for whatever reason, so that the Company may
determine whether to assert a claim under this Section or any other provision of this Agreement.

 

    	 	Page 4 of 17	Initials:       /_    

     

    

 

2.08 Equitable Relief.
Executive acknowledges that his services to the Company are of a unique character which give them a special value to the Company.
Executive further recognizes that violations by Executive of any one or more of the provisions of this Section 2 may give rise
to losses or damages for which the Company cannot be reasonably or adequately compensated in an action at law and that such violations
may result in irreparable and continuing harm to the Company. Executive agrees that, therefore, in addition to any other remedy
which the Company may have at law and equity, including the right to withhold any payment of compensation under Section 4 of this
Agreement, the Company shall be entitled to injunctive relief, without posting any bond or showing actual damages, to restrain
any violation, actual or threatened, by Executive of the provisions of this Agreement.

 

3      Compensation.

 

3.01 Minimum Annual Compensation.
The Company shall pay to Executive for the services to be rendered hereunder a base salary at an annual rate of Two Hundred Forty
Thousand and 00/100 Dollars ($240,000.00) (the “Minimum Annual Compensation”). There shall be an annual review for
merit by the Board and an increase as deemed appropriate to reflect the value of services by Executive. At no time during the Term
of this Agreement shall Executive's annual base salary fall below the Minimum Annual Compensation. In addition, if the Board increases
the Minimum Annual Compensation at any time during the Term of this Agreement, such increased Minimum Annual Compensation shall
become a floor below which Executive's compensation shall not fall at any future time during the Term of this Agreement and shall
become Minimum Annual Compensation.

 

Executive's salary shall be payable in periodic installments
in accordance with the Company’s usual practice for Executives of the Company.

 

3.02 Incentive Compensation.
In addition to the Minimum Annual Compensation, Executive shall be entitled to receive payments as set forth herein:

 

(a) Bonus Programs. Under
the Company’s incentive compensation and/or bonus program(s) (as in effect from time to time), if any (“Incentive Compensation”),
in such amounts as are determined by the Company to be appropriate for Executives of the Company. Any Incentive Compensation which
is not deductible, in the opinion of the Company’s counsel, under § 162(m) of the Internal Revenue Code shall except
as otherwise provided in this Agreement be deferred and paid, without interest, in the first (1st) year or years when and to the
extent such payment may be deducted, Executive's right to such payment being absolute, subject only to the provisions of Section
2.08.

 

(b) Performance Bonus. Notwithstanding
anything to the contrary in this Agreement, in addition to the payments and other benefits described in this Section 3 above, Executive
shall be entitled to a Performance Bonus while rendering services under this Agreement. Such bonus shall be calculated as follows:
the Performance Bonus shall be based on the Net Operating Profit before Income Taxes as shown on the Annual Financial Statements
or as provided by the accountants regularly engaged by the Company. This Performance Bonus shall be calculated as follows:

 

	Net Operating Profit before Income Taxes	 	Performance Bonus
	 	 	 
	On the First $10 Million	 	4.0% of the Net Operating Profit On all Amounts
	Over $10 Million	 	3.0% of the Net Operating Profit

  

Notwithstanding anything to the
contrary in this Agreement, all bonuses described herein shall be paid within thirty (30) days after the audited Annual Financial
Statements are completed and furnished to the Company or filed with the SEC, whichever is earlier. In the event Executive's employment
is for a period less than the entire year covered by the Annual Financial Statements, Executive shall be entitled to a prorated
bonus. The prorated bonus shall be the amount Executive would have received if Executive had been employed as Chief Executive Officer
or in such similar capacity for the entire annual period, prorated to the portion of the annual period Executive was actually employed
as such.

 

    	 	Page 5 of 17	Initials:       /_    

     

    

 

3.03 Participating in Benefits.
Executive shall be entitled to all Benefits for as long as such Benefits may remain in effect and/or any substitute or additional
Benefits made available in the future to Executives of the Company, subject to and on a basis consistent with the terms, conditions,
and overall administration of such Benefits adopted by the Company. Benefits paid to Executive shall not be deemed to be in lieu
of other compensation to Executive hereunder as described in this Section 3.

 

3.04 Specific Benefits. During the term of
this Agreement (and thereafter to the extent this Agreement shall require):

 

(i) Executive shall be entitled
to five (5) weeks of paid vacation time per year, to be taken at times mutually acceptable to the Company and Executive.

 

(ii) The Company shall provide
fully paid accident and health insurance for Executive and his family unless waived by Executive in writing. Any waiver of such
benefits may be revoked at any time by Executive.

 

(iii) In recognition of the necessity
of the use of an automobile to the efficient and expeditious performance of Executive's services, duties and obligations to and
on behalf of the Company, the Company shall provide to Executive, at the Company’s sole cost and expense, two vehicles to
be chosen by Executive, one in the Orlando, Florida, metropolitan region and one in the Houston, Texas, metropolitan region, with
an aggregate leasing cost to the Company for both vehicles of not more than two thousand and 00/100 dollars ($2,000) per month.
In addition thereto, the Company shall bear the expense of insurance, fuel, and maintenance of said vehicle.

 

(iii) In addition to the vacation
provided pursuant to Section 3.04 (A) hereof, Executive shall be entitled to not less than ten (10) paid holidays (other than weekends)
per year, generally on such days on which the New York Stock Exchange is closed to trading.

 

(iv) Executive shall be entitled
to receive prompt reimbursement for all reasonable business expenses incurred by him (in accordance with the policies and procedures
established by the Company or the Board for the similarly situated Executives of the Company) in performing services hereunder.

 

(vi) Upon submission of travel
and expense reports accompanied by proper vouchers, the Company will pay or reimburse Executive for all transportation, hotel,
living, and related expenses incurred by Executive on business trips away from the Company’s principal office, and for all
other business and entertainment expenses reasonably incurred by him in connection with the business of the Company and its subsidiaries
and affiliates during the term of this Agreement.

 

(vii) Executive shall be eligible
to participate during the Employment Period in Benefits not inconsistent or duplicative of those set forth in this Section 3.04
as the Company shall establish or maintain for its Executives or executives generally.

 

(viii) During and following the
Term of this Agreement, the Company shall indemnify and hold the Executive harmless to the maximum extent permitted under the Private
Corporations Law of Nevada for acts taken within the scope of his employment. To the extent that the Company obtains coverage under
a director and officer indemnification policy, the Executive shall be entitled to such coverage on a basis that is no less favorable
than the coverage provided to any other officer or director of the Company. This provision shall survive termination of this Agreement.

 

3.05       Indemnification.
The Company will indemnify and hold harmless the Executive to the fullest extent permitted in Nevada Revised Statutes Chapter 78
(Private Corporations Law) in connection with the defense of any action, suit or proceeding to which he is a party or threatened
thereby, by reason of his being or having been an officer or director of the Company. The right to indemnification provided by
this Section 3.06 shall be superseded as of the effective date of any indemnification agreement entered into between the Company
and its directors and executives by the terms of such indemnification agreement.

 

    	 	Page 6 of 17	Initials:       /_    

     

    

 

4.      Termination of
Employment.

 

4.01. Death or Permanent
Disability. The Executive’s employment shall terminate automatically upon the Executive’s death during the Term
hereof. If the Company determines in good faith that the Permanent Disability of the Executive has occurred during the Term of
this Agreement (pursuant to the definition of Permanent Disability set forth below), it may provide the Executive with written
notice in accordance with Section 8.09 of this Agreement of its intention to terminate the Executive’s employment. In such
event, the Executive’s employment with the Company shall terminate effective on the thirtieth (30th) day after receipt of
such notice by the Executive (the “Disability Effective Date”), provided that, within the 30 days after such receipt,
the Executive shall not have returned to full-time performance of the Executive’s duties. For purposes of this Agreement,
“Permanent Disability” shall have such meaning as under the Company’s disability plan in which the Executive
participates or, if the Executive does not participate in any such plan, shall mean the absence of the Executive from the Executive’s
duties with the Company on a full-time basis for one hundred eighty (180) consecutive business days as a result of incapacity due
to mental or physical illness, as determined by a physician selected by the Company or its insurers and acceptable to the Executive
or the Executive’s legal representative.

 

4.02. Termination for Cause.
The Company may terminate the Executive’s employment during the Term hereof either with or without Cause. For purposes of
this Agreement, “Cause” shall mean:

 

(i) the willful failure of the
Executive to perform the Executive’s duties with the Company (other than any such failure resulting from incapacity due to
physical or mental illness) which Executive fails to correct within fifteen (15) days of receiving written notice of the Board's
intention to terminate Executive if such failure or conduct is not corrected;

 

(ii) the willful engaging by
the Executive in illegal conduct or willful misconduct which is materially and demonstrably injurious to the Company;

 

(iii) the Executive’s conviction of, or plea of guilty
or nolo contendere to, a charge of commission of a felony;

 

(iv) the Executive’s disclosure
of confidential information in violation of the Company’s written policies which is materially and demonstrably injurious
to the Company which Executive fails to correct within fifteen (15) days of receiving written notice of the Board’s intention
to terminate Executive if such failure or conduct is not corrected; or

 

(v) the Executive’s material
willful breach of this Agreement which Executive fails to correct within fifteen (15) days of receiving written notice of the Board’s
intention to terminate Executive if such failure or conduct is not corrected.

  

For purposes of this Section,
no act or failure to act, on the part of the Executive, shall be considered “willful” unless it is done, or omitted
to be done, by the Executive in bad faith or without reasonable belief that the Executive’s action or omission was in the
best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by
the Board or upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by the
Executive in good faith and in the best interests of the Company. The cessation of employment of the Executive shall not be deemed
to be for Cause unless and until there shall have been delivered to the Executive a copy of a resolution duly adopted by the affirmative
vote of not less than a majority of the entire membership of the Board at a meeting of the Board called and held for such purpose
(after reasonable notice is provided to the Executive and the Executive is given an opportunity, together with counsel, to be heard
before the Board), finding that, in the good faith opinion of the Board, the Executive is guilty of the conduct described in clauses
(i), (ii) or (iv) above, and specifying the particulars thereof in detail.

 

    	 	Page 7 of 17	Initials:       /_    

     

    

 

4.03 Good Reason.
“Good Reason” shall mean (in the absence of the written consent of the Executive):

 

(i) any failure by the Company to comply with any of the provisions
of Section 3 of this Agreement, other than an isolated, insubstantial and inadvertent failure not occurring in bad faith and that
is remedied by the Company promptly after receipt of notice thereof given by the Executive;

 

(ii)  any other material
breach of this Agreement by the Company;

 

(iii)  any failure by
the Company to comply with Section 8.01 of this Agreement; or

  

(iv)  an event that
results in a Change of Control occurs.

 

The Executive’s mental or physical incapacity following
the occurrence of an event described above in clauses (i) through (iv) shall not affect the Executive’s ability to terminate
employment for Good Reason and the Executive’s death following delivery of a Notice of Termination for Good Reason shall
not affect the Executive’s estate’s entitlement to any severance payments or benefits under Section 5(a) of this Agreement.
For purposes of providing notice pursuant to this Section, either Executive or Executives attorney-in-fact, personal representative,
executor, or other legal representative (including but not limited to Executive’s attorney) may deliver the requisite notices
described herein.

  

4.04 Notice of Termination.
Any termination by the Company for Cause, or by the Executive for Good Reason, shall be communicated by Notice of Termination to
the other party hereto given in accordance with Section 8.05 of this Agreement. For purposes of this Agreement, a “Notice
of Termination” means a written notice which (i) indicates the specific termination provision in this Agreement relied upon,
(ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination
of the Executive’s employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is
other than the date of receipt of such notice, specifies the termination date (which date shall be not more than 30 days after
the giving of such notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance
which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company, respectively,
hereunder or preclude the Executive or the Company, respectively, from asserting such fact or circumstance in enforcing the Executive’s
or the Company’s rights hereunder.

 

4.05 Date of Termination.
“Date of Termination” means (i) if the Executive’s employment is terminated by the Company for Cause or by the
Executive with or without Good Reason, the date of receipt of the Notice of Termination or any later date specified therein within
thirty (30) days of such notice, as the case may be, (ii) if the Executive’s employment is terminated by the Company other
than for Cause or Permanent Disability, the Date of Termination shall be the date on which the Company notifies the Executive of
such termination, and (iii) if the Executive’s employment is terminated by reason of death or Permanent Disability, the Date
of Termination shall be the date of death of the Executive or the Disability Effective Date, as the case may be. The Company and
the Executive shall take all steps necessary (including with regard to any post-termination services by the Executive) to ensure
that any termination described in this Section 4 constitutes a “separation from service” within the meaning of Section
409A of the Code, and notwithstanding anything contained herein to the contrary, the date on which such separation from service
takes place shall be the “Date of Termination.”

 

    	 	Page 8 of 17	Initials:       /_    

     

    

 

5      Obligations of the Company upon Termination.

 

5.01 Good Reason or
Without Cause. Subject to the Executive’s execution of the “Waiver and Release” attached hereto as
Exhibit A (the “Waiver and Release”) no later than thirty (30) days after the Date of Termination, if, during the
Term of this Agreement, the Company shall terminate the Executive’s employment without Cause or the Executive shall
terminate employment for Good Reason:

 

(i) The Company shall pay to the
Executive in a lump sum in cash within thirty (30) days after the Date of Termination (or, if later, five (5) days after the effective
date of the Waiver and Release), the aggregate of the following amounts:

 

A. the sum of (1) the Executive’s
Annual Minimum Salary through the Date of Termination to the extent not theretofore paid, (2) any annual incentive payment earned
by the Executive for a prior period to the extent not theretofore paid and not theretofore deferred, (3) any Annual Performance
Bonus Payment earned by the Executive for a prior period to the extent not theretofore paid and not theretofore deferred, (4) any
accrued and unused vacation pay and (5) any business expenses incurred by the Executive that are unreimbursed as of the Date of
Termination (the sum of the amounts described in clauses (1)-(5), shall be hereinafter referred to as the “Accrued Obligations”);

 

B. the product of (1) the Performance
Bonus Payment and (2) a fraction, the numerator of which is the number of days that have elapsed in the fiscal year of the Company
in which the Date of Termination occurs as of the Date of Termination, and the denominator of which is 365 (the “Pro-Rata
Performance Bonus”);

 

C. the amount equal to the sum
of (i) the Executive’s Annual Minimum Salary; (ii) the Performance Bonus Payment and (iii) the Incentive Payment (i-iii collectively,
the “Severance Payment”);

 

D. in the event Executive is
not fully vested in any retirement benefits with the Company from pension, profit sharing, or any other qualified or non-qualified
retirement plan(s), the difference between the amounts Executive would have been paid if he had been vested on the date his employment
was terminated and the amounts paid or owed to the Executive pursuant to such retirement plans;

 

E. the product of (1) the Incentive
Payment and (2) a fraction, the numerator of which is the number of days that have elapsed in the fiscal year of the Company in
which the Date of Termination occurs as of the Date of Termination, and the denominator of which is 365 (the “Pro-Rata Incentive
Payment”); and

 

F. the present value of the
amount equal to the sum of five (5) years’ Performance Bonus pay with such amount being calculated based on the Performance
Bonus paid to the Employee the year prior to Termination.

 

(ii) Notwithstanding anything
to the contrary contained in any stock incentive plan or grant or award agreement, as applicable:

 

A. All stock options and warrants
outstanding as of the Date of Termination and held by the Executive shall vest in full and become immediately exercisable for the
remainder of their full term;

 

B. All restricted stock shall no longer
be restricted to the extent permitted by law. The Company will use its best efforts, at its sole cost to register such restricted
stock as expeditiously as possible (A and B collectively, the “Equity Benefits”).

 

(iii) To the extent not theretofore paid
or provided, the Company shall timely pay or provide to the Executive any other amounts or benefits required to be paid or provided
or which the Executive is eligible to receive under any plan, program, policy or practice or contract or agreement of the Company
through the Date of Termination, and, to the extent the Executive satisfies any “retirement” based rule of any of the
foregoing that provides for more beneficial treatment to the Executive, the Executive shall be afforded such more beneficial treatment
(such other amounts and benefits and such more beneficial treatment shall be hereinafter referred to as the “Other Benefits”).

 

    	 	Page 9 of 17	Initials:       /_    

     

    

 

5.02 Death. If the Executive’s
employment is terminated by reason of the Executive’s death during the Employment Period, this Agreement shall terminate
without further obligations to the Executive’s legal representatives under this Agreement, other than for payment of Accrued
Obligations, the Pro-Rata Performance Bonus Payment, the Pro-Rata Incentive Payment, the Equity Benefits, the provision of the
Retiree Coverage for the Executive’s spouse as of the date hereof and the timely payment or provision of the Other Benefits.
Accrued Obligations, the Pro- Rata Performance Bonus Payment, and Pro-Rata Incentive Payment shall be paid to the Executive’s
estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination, and the payment in respect
of the Retiree Coverage (which will be in addition to any rights to COBRA Coverage) shall be paid as soon as reasonably practicable
following the Executive’s death but in no event later than the end of the COBRA Coverage period. With respect to the provision
of Other Benefits, the term Other Benefits as utilized in this Section 5.02 shall include, and the Executive’s estate shall
be entitled after the Date of Termination to receive, death benefits as in effect at the Date of Termination generally with respect
to senior executives of the Company.

 

5.03 Permanent Disability.
If the Executive’s employment is terminated by reason of the Executive’s Permanent Disability during the Employment
Period, this Agreement shall terminate without further obligations to the Executive, other than for payment of Accrued Obligations,
the Pro-Rata Performance Bonus Payment, the Pro-Rata Incentive Payment and the Severance Payment, the Equity Benefits, the provision
of the Medical Benefits in accordance with the 409A Medical Benefits Treatment, and the timely payment or provision of the Other
Benefits. Accrued Obligations, the Pro-Rata Performance Bonus Payment, the Pro-Rata Incentive Payment, and the Severance Payment
shall be paid to the Executive in a lump sum in cash within 30 days of the Date of Termination, provided, that in the event that
the Executive is a Specified Executive, the Pro-Rata Performance Bonus Payment and the Severance Payment shall be paid, with Interest,
to the Executive on the Delayed Payment Date. In addition, in the event that the Executive is a Specified Executive, any cash payments
in respect of the Retiree Coverage shall be paid to the Executive (or, as applicable, his spouse on the date hereof) on the later
of (i) the Delayed Payment Date and (ii) the date that such payments would have otherwise been paid pursuant to the Retiree Coverage.
With respect to the provision of Other Benefits, the term Other Benefits as utilized in this Section 5.03 shall include, and the
Executive shall be entitled after the Disability Effective Date to receive, disability and other benefits as in effect at any time
thereafter generally with respect to senior executives of the Company.

 

5.04 Cause.
If the Executive’s employment shall be terminated for Cause this Agreement shall terminate without further obligations
to the Executive other than the obligation to pay or provide to the Executive (A) the Accrued Obligations and (B) the Other
Benefits. Accrued Obligations shall be paid to the Executive in a lump sum in cash within 30 days of the Date of
Termination.

 

5.05 Other than for Good
Reason. If the Executive’s employment shall be terminated by the Executive without Good Reason, this Agreement shall
terminate without further obligations to the Executive other than the obligation to pay or provide to the Executive (A) the Accrued
Obligations, (B) the Other Benefits, and (C) the Retiree Coverage. Accrued Obligations shall be paid to the Executive in a lump
sum in cash within 30 days of the Date of Termination. In addition, in the event that the Executive is a Specified Executive, any
cash payments in respect of the Retiree Coverage shall be paid to the Executive (or, as applicable, his spouse on the date hereof)
on the later of (i) the Delayed Payment Date and (ii) the date that such payments would have otherwise been paid pursuant to the
Retiree Coverage.

 

6      Full Settlement; Legal
Fees. The Company’s obligation to make the payments provided for in this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right, or action which the Company
may have against the Executive or others. In no event shall the Executive be obligated to seek other employment or take any other
action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and such amounts
shall not be reduced whether or not the Executive obtains other employment. The Company agrees to pay as incurred, to the full
extent permitted by law, all legal fees and expenses that the Executive may reasonably incur as a result of any contest by the
Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any
guarantee of performance thereof (including as a result of any contest by the Executive about the amount of any payment pursuant
to this Agreement), plus, in each case, Interest, provided that the Executive prevails on any material issue in such contest. In
order to comply with Section 409A of the Code, (i) in no event shall the payments by the Company under this Section 6 be made later
than the end of the calendar year next following the calendar year in which such fees and expenses were incurred, provided, that
the Executive shall have submitted an invoice for such fees and expenses at least 10 days before the end of the calendar year next
following the calendar year in which such fees and expenses were incurred; (ii) the amount of such legal fees and expenses that
the Company is obligated to pay in any given calendar year shall not affect the legal fees and expenses that the Company is obligated
to pay in any other calendar year; (iii) the Company’s obligation to pay the Executive’s legal fees shall terminate
on the 20th anniversary of the Effective Date; and (iv) the Executive’s right to have the Company pay such legal fees and
expenses may not be liquidated or exchanged for any other benefit.

 

    	 	Page 10 of 17	Initials:       /_    

     

    

 
 

7      Certain
Additional Payments by the Company.

 

7.01 Excise Taxes;
Interest; Penalties. Anything in this Agreement to the contrary notwithstanding and except as set forth below, in the
event it shall be determined that any payment or distribution by, or benefit from, the Company or any person who acquires
ownership or effective control or ownership of a substantial portion of the Company’s assets (within the meaning of
section 280G of the Code) or by any affiliate of such person, to or for the benefit of Executive (whether paid or payable or
distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard to any
additional payments required under this Section 7) (a “Payment”) would be subject to the excise tax
imposed by section 4999 of the Code or any interest or penalties are incurred by Executive with respect to such excise tax
(such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the
“Excise Tax”), then Executive shall be entitled to receive an additional payment (a “Gross-Up
Payment”) in an amount such that after payment by Executive of all taxes (including any interest or penalties
imposed with respect to such taxes), including without limitation, any income taxes (and any interest and penalties imposed
with respect thereto) and Excise Tax imposed upon the Gross-Up Payment, Executive retains an amount of the Gross-Up Payment
equal to the Excise Tax imposed upon the Payments. Any Gross-Up Payment that the Company is required to make to reimburse
Executive for federal, state and local taxes imposed upon Executive, including the amount of additional taxes imposed upon
Executive due to the Company’s payment of the initial taxes on such amounts, shall be made by the Company by the end of
Executive’s taxable year next following Executive’s taxable year in which Executive remits the related taxes to
the taxing authority.

 

7.02 Fees and Expenses Determined
by Accounting Firm. Subject to the provisions of Section 7.03, all determinations required to be made under this Section 7,
including whether and when a Gross-Up Payment is required and the amount of such Gross-Up Payment and the assumptions to be utilized
in arriving at such determination, shall be made by a certified public accounting firm that is (i) not serving as accountant or
auditor for the person who acquires ownership or effective control or ownership of a substantial portion of the Company’s
assets (within the meaning of section 280G of the Code) or any Affiliate of such person and (ii) agreed upon by the Company and
Executive (the “Accounting Firm”). The Accounting Firm shall provide detailed supporting calculations both to
the Company and Executive within 15 business days after appointment by the Company and Executive and receipt of notice from Executive
that there has been a Payment, or such earlier time as is requested by the Company. All fees and expenses of the Accounting Firm
shall be borne solely by the Company. Any Gross-Up Payment, as determined pursuant to this Section 7 shall be paid by the Company
to Executive within five days after the receipt of the Accounting Firm’s determination and in no event later than the payment
deadline specified in Section 7.01 Any determination by the Accounting Firm shall be binding upon the Company and Executive. As
a result of the uncertainty in the application of section 4999 of the Code at the time of the initial determination by the Accounting
Firm hereunder, it is possible that Gross-Up Payments that will not have been made by the Company should have been made (“Underpayment”),
consistent with the calculations required to be made hereunder. In the event that the Company exhausts its remedies pursuant to
Section 7.03 and Executive thereafter is required to make a payment of any Excise Tax, the Accounting Firm shall determine the
amount of the Underpayment that has occurred and any such Underpayment shall be promptly paid by the Company to or for the benefit
of Executive.

 

7.03 Higher Payments Demanded
by Taxing Authority(ies). Executive shall notify the Company in writing of any claim by the Internal Revenue Service, state
or other taxing authority (“Taxing Authority”) that, if successful, would require the payment by the Company
of the Gross-Up Payment (or an additional Gross-Up Payment) in the event the Taxing Authority seeks higher payment. Such notification
shall be given as soon as practicable, but no later than ten business days after Executive is informed in writing of such claim,
and shall apprise the Company of the nature of such claim and the date on which such claim is requested to be paid. Executive shall
not pay such claim prior to the expiration of the 30-day period following the date on which he gives such notice to the Company
(or such shorter period ending on the date that any payment of taxes with respect to such claim is due). If the Company notifies
Executive in writing prior to the expiration of such period that it desires to contest such claim, Executive shall:

 

(i) give the Company any information
reasonably requested by the Company relating to such claim,

 

(ii) take such action in connection
with contesting such claim as the Company shall reasonably request in writing from time to time, including without limitation,
accepting legal representation with respect to such claim by an attorney reasonably selected by the Company,

 

(iii) cooperate with the Company
in good faith in order to effectively contest such claim, and

 

    	 	Page 11 of 17	Initials:       /_    

     

    

 

(iv) permit
the Company to participate in any proceedings relating to such claim;

 

provided,
however, that the Company shall bear and pay directly all costs and expenses (including additional interest and penalties) incurred
at any time during the period that ends ten years following the lifetime of Executive in connection with such proceedings and shall
indemnify and hold Executive harmless, on an after-tax basis, for any Excise Tax and income tax (including interest and penalties
with respect thereto) imposed as a result of such representation and payment of costs and expenses. Without limitation on the foregoing
provisions of this Section 7.03, the Company shall control all proceedings taken in connection with such contest and, at its sole
option, may pursue or forego any and all administrative appeals, proceedings, hearings and conferences with the Taxing Authority
in respect of such claim and may, at its sole option, either direct Executive to pay the tax claimed and sue for a refund or contest
the claim in any permissible manner, and Executive agrees to prosecute such contest to determination before any administrative
tribunal, in a court of initial jurisdiction and in one or more appellate courts, as the Company shall determine; provided, however,
that if the Company directs Executive to pay such claim and sue for a refund, the Company shall advance the amount of such payment
to Executive, on an interest-free basis and shall indemnify and hold Executive harmless, on an after-tax basis, from any Excise
Tax or income tax (including interest or penalties with respect thereto) imposed with respect to such advance or with respect to
any imputed income with respect to such advance; and further provided that any extension of the statute of limitations relating
to payment of taxes for the taxable year of Executive with respect to which such contested amount is claimed to be due is limited
solely to such contested amount. The Company shall not direct Executive to pay such a claim and sue for a refund if, due to the
prohibitions of section 402 of the Sarbanes-Oxley Act of 2002, the Company may not advance to Executive the amount necessary to
pay such claim. The Company’s control of the contest shall be limited to issues with respect to which a Gross-Up Payment
would be payable hereunder and Executive shall be entitled to settle or contest, as the case may be, any other issues raised by
the Taxing Authority.
The costs and expenses that are subject to be paid pursuant to this Section 7.03 shall not be limited as a result of when the costs
or expenses are incurred. The amounts of costs or expenses that are eligible for payment pursuant to this Section 7.03 (iv) during
a given taxable year of Executive shall not affect the amount of costs or expenses eligible for payment in any other taxable year
of Executive. The right to payment of costs and expenses pursuant to this Section 7.03 (iv) is not subject to liquidation or exchange
for another benefit. Any payment due under this Section 7.03 (iv) to reimburse Executive for any taxes shall be made to Executive
by the Company by the end of Executive’s taxable year following Executive’s taxable year in which Executive remits
the related taxes to the applicable taxing authorities.

 

7.04 Refunds. If, after
the receipt by Executive of an amount advanced by the Company pursuant to Section 7.03, Executive becomes entitled to receive any
refund with respect to such claim, Executive shall (subject to the Company’s complying with the requirements of Section 7.03
promptly pay to the Company the amount of such refund (together with any interest paid or credited thereon after taxes applicable
thereto. If, after the receipt by Executive of an amount advanced by the Company pursuant to Section 7.03, a determination is made
that Executive shall not be entitled to any refund with respect to such claim and the Company does not notify Executive in writing
of its intent to contest such denial of refund prior to the expiration of 30 days after such determination, then such advance shall
not be required to be repaid.

 

8      Miscellaneous.

 

8.01 Assignment. This
Agreement and the rights and obligations of the parties hereto shall bind and inure to the benefit of each of the parties hereto
and shall also bind and inure to the benefit of any successor or successors of the Company in a reorganization, merger, or consolidation
and any assignee of all or substantially all of the Company’s business and properties, but, except as to any such successor
of the Company, neither this Agreement nor any rights or benefits hereunder may be assigned by the Company or Executive. This Agreement
and any rights and benefits hereunder shall inure to the benefit of and be enforceable by the Executive's legal representatives,
heirs and legatees.

 

8.02 Governing Law; Jurisdiction;
Venue. This Agreement shall be construed in accordance with and governed for all purposes by the laws of the State of New York,
without giving effect to any principles of conflicts of law thereunder. In any action brought to enforce this Agreement, the exclusive
jurisdiction and venue shall be the Business Court of Orange County, Florida, without regard to any conflicts of law.

 

8.03 Interpretation.
In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal, or
unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provisions of this Agreement,
but this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

    	 	Page 12 of 17	Initials:       /_    

     

    

 

8.04 Notice. Any notice
required or permitted to be given hereunder shall be effective when received and shall be sufficient if in writing and if personally
delivered or sent by prepaid cable, telex or registered air mail, return receipt requested, to the party to receive such notice
at its address set forth at the end of this Agreement or at such other address as a party may by notice specify to the other. With
respect to electronic mail communications, such communications shall be deemed effective only upon receipt of responsive electronic
mail confirmation from the receiving party to the delivering party that such mail was, in fact, received (read e-mail confirmations
satisfy this notice requirement).

 

8.05 Amendment and Waiver.
This Agreement may not be amended, supplemented or waived except by a writing signed by the party against which such amendment
or waiver is to be enforced. The waiver by any party of a breach of any provision, of this Agreement shall not operate to, or be
construed as a waiver of, any other breach of that provision nor as a waiver of any breach of another provision.

 

8.06 Binding Effect.
Subject to the provisions of Sections 5 and 8.01 hereof, this Agreement shall be binding on, and inure to the benefit of, the successors
and assigns of the parties hereto.

 

8.07 Survival of Rights and
Obligations. All rights and obligations of Executive or the Company arising during the term of this Agreement shall continue
to have full force and effect after the termination of this Agreement unless otherwise provided herein.

 

8.08 Effective Date and Prior
Employment Agreement. Executive and the Company agree that the Effective Date of this Agreement is the date first written at
the beginning of this Agreement. All prior employment agreements between the Company and Executive are hereby terminated and superseded
as of the Effective Date, provided that all rights of the Executive to any compensation or benefits which have accrued under the
prior agreements and any time or vesting accrued in the Company or any of its benefit, pension, profit-sharing, bonus, incentive
or other plans shall be carried over.

 

    	 	Page 13 of 17	Initials:       /_    

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Employment Agreement to be duly executed as of the day and year first above written.

 

	COMPANY:	 	EXECUTIVE:
    
	 	 	 	 
	LIFESTYLE
    MEDICAL NETWORK INC.	 	 
	a
    Nevada corporation	 	 
	 	 	 	 
	By:	/s/
    Gerald Goodman	 	/s/
    Chris Smith
	 	 	 	 
	Title:	Director	 	Christopher
    P. Smith

  

    	 	Page 14 of 17	Initials:       /_    

     

    

 

Exhibit A

 

WAIVER AND RELEASE

 

PLEASE READ THIS WAIVER AND RELEASE
CAREFULLY. IT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS UP TO AND INCLUDING THE DATE THAT THIS AGREEMENT AND RELEASE IS
EXECUTED BY THE EXECUTIVE.

 

For and in consideration of the payments
and other benefits due to Christopher P. Smith
(the “Executive”) pursuant to the Employment Agreement (the “Employment Agreement”) entered into as of
July 1, 2017 (the “Effective Date”), by and between                             
INC. (the “Company”) and the Executive, and for other good and valuable consideration, the Executive irrevocably
and unconditionally releases and forever discharges the Company and each and all of its present and former officers, agents, directors,
managers, Executives, representatives, affiliates, shareholders, members, and each of their successors and assigns, and all persons
acting by, through, under or in concert with it, and in each case individually and in their official capacities (collectively,
the “Released Parties”), from any and all charges, complaints, grievances, claims and liabilities of any kind or nature
whatsoever, known or unknown, suspected or unsuspected (hereinafter referred to as “claim” or “claims”)
which the Executive at any time heretofore had or claimed to have or which the Executive may have or claim to have regarding events
that have occurred up to and including the date of the Executive’s execution of this Release, including, without limitation,
any and all claims related, in any manner, to the Executive’s employment or the termination thereof. In particular, the
Executive understands and agrees that the Executive’s release includes, without limitation, all matters arising under any
federal, state, or local law, including civil rights laws and regulations prohibiting employment discrimination on the basis of
race, color, religion, age, sex, national origin, ancestry, disability, medical condition, veteran status, marital status and
sexual orientation, or any other characteristic protected by federal, state or local law including, but not limited to, claims
under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act of 1967, as amended, the
Older Workers Benefit Protection Act of 1990, as amended, the Americans with Disabilities Act, the Rehabilitation Act, the Occupational
Safety and Health Act, the Family and Medical Leave Act, the Executive Retirement Income Security Act of 1974 (except as to vested
benefits, if any), the Worker Adjustment and Retraining Notification Act, the Equal Pay Act, the Fair Labor Standards Act, as
amended , the District of Columbia Human Rights Act, as amended, the New York City Administrative Code, as amended, the New York
Labor Law, as amended, the Maryland Human Relations Act, the New York Executive Law, as amended, the District of Columbia Wage
Payment and Wage Collection Law, as amended, the Maryland Wage Payments and Collection Act, as amended, claims arising out of
any legal restrictions on an employer's right to terminate its employees in any jurisdiction, such as claims for wrongful or constructive
discharge, breach of any express or implied contract, and/or any claims on any basis whatsoever regarding your status, pay position,
or title while employed by the Company, federal and state wage and hour laws, or any common law, public policy, contract (whether
oral or written, express or implied) or tort law, or any other federal, state or local law, regulation, ordinance or rule having
any bearing whatsoever.

 

    	 	Page 15 of 17	Initials:       /_    

     

    

 

The Executive shall have thirty
(30) days from the Date of Termination to sign and return this Release by personal or guaranteed overnight delivery to the attention
of LIFESTYLE MEDICAL NETWORK INC., a Nevada corporation. Notwithstanding anything to the contrary in this Release, the Executive
can revoke this Release within seven days after executing the Release by sending written notification to the Company of Executive’s
intent to revoke the Release, and this Release shall not become effective or enforceable until such revocation period has expired.
The Executive’s written notification of the intent to revoke the Release must be sent to LIFESTYLE MEDICAL NETWORK INC.,
a Nevada corporation by personal delivery or guaranteed overnight delivery, at:

 

121 S. Orange Ave

Suite 1500

Orlando, FL 32801

 

, within seven (7) days after the Executive executed the Release.

 

The Executive acknowledges that
he/she may have sustained losses that are currently unknown or unsuspected, and that such damages or losses could give rise to
additional causes of action, claims, demands and debts in the future. Nevertheless, the Executive acknowledges that this Release
has been agreed upon in light of this realization and, being fully aware of this situation, the Executive nevertheless intends
to release the Company from any and all such unknown claims, including damages which are unknown or unanticipated. The parties
understand the word “claims” to include all actions, claims, and grievances, whether actual or potential, known or
unknown, and specifically but not exclusively all claims arising out of the Executive’s employment and the termination thereof.
All such “claims” (including related attorneys’ fees and costs) are forever barred by this Release and without
regard to whether those claims are based on any alleged breach of a duty arising in a statute, contract, or tort; any alleged unlawful
act, including, without limitation, age discrimination; any other claim or cause of action; and regardless of the forum in which
it might be brought.

 

Notwithstanding anything else
herein to the contrary, this Release shall not affect, and the Executive does not waive: (i) rights to indemnification the Executive
may have under (A) applicable law, (B) any other agreement between the Executive and a Released Party and (C) as an insured under
any director’s and officer’s liability insurance policy now or previously in force; (ii) any right the Executive may
have to obtain contribution in the event of the entry of judgment against the Executive as a result of any act or failure to act
for which both the Executive and any of its affiliates or subsidiaries (collectively, the “Affiliated Entities”) are
jointly responsible; (iii) the Executive’s rights to benefits and payments under any stock options, restricted stock, restricted
stock units or other incentive plans or under any retirement plan, welfare benefit plan or other benefit or deferred compensation
plan, all of which shall remain in effect in accordance with the terms and provisions of such benefit and/or incentive plans and
any agreements under which such stock options, restricted shares, restricted stock units or other awards or incentives were granted
or benefits were made available; (iv) the Executive’s rights as a stockholder of any of the Affiliated Entities; or (v) any
obligations of the Affiliated Entities under the Employment Agreement.

 

    	 	Page 16 of 17	Initials:       /_    

     

    

 

The Executive acknowledges
and agrees that the Executive: (a) has been given at least 21 days within which to consider this Release and its
ramifications and discuss the terms of this Release with the Company before executing it (and that any modification of this
Release, whether material or immaterial, will not restart or change the original consideration period) and the Executive
fully understands that by signing below the Executive is voluntarily giving up any right which the Executive may have to sue
or bring any other claims against the Released Parties; (b) has been given seven days after returning the Release to the
Company to revoke this Release; (c) has been advised to consult legal counsel regarding the terms of this Release; (d) has
carefully read and fully understands all of the provisions of this Release; (e) knowingly and voluntarily agrees to all of
the terms set forth in this Release; and (f) knowingly and voluntarily intends to be legally bound by the same. The Executive
also agrees that to the extent permitted by law, Executive shall not (i) file a charge or complaint with the Equal Employment
Opportunity Commission or Department of Fair Employment and Housing or any other federal, state or local administrative or
regulatory agency, or (ii) participate in any investigation or proceedings conducted by the Equal Employment Opportunity
Commission or Department of Fair Employment and Housing or any other federal, state or local administrative or regulatory
agency. Notwithstanding anything in this Release to the contrary, nothing in this Release shall be construed to prohibit the
Executive from (i) filing a charge or complaint with the Equal Employment Opportunity Commission or Department of Fair
Employment and Housing or any other federal, state or local administrative or regulatory agency, or (ii) participating in any
investigation or proceedings conducted by the Equal Employment Opportunity Commission or Department of Fair Employment and
Housing or any other federal, state or local administrative or regulatory agency if Executive’s waiver of such rights
under the preceding sentence is deemed unenforceable, illegal or against public policy. However, in such event, the Executive
expressly waives the right to any relief of any kind should the Equal Employment Opportunity Commission or Department of Fair
Employment and Housing or any other federal, state or local administrative or regulatory agency pursue any claim on
the Executive’s behalf.

 

This Release is final and binding and may not be changed
or modified except in a writing signed by both parties.

 

LIFESTYLE MEDICAL NETWORK INC.

a Nevada corporation

 

	 	 	 
	Print Name:                                                    

	 	CHRISTOPHER P. SMITH
	Title:                                                               	 	 
	Date:                                                              	 	Date:
	 	 	 

  

 

	 	Page 17 of 17	Initials:       /_

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]